Estimating HIV levels and trends among patients of tuberculosis clinics.
Symptomatic tuberculosis (TB) can occur as an opportunistic disease in immunosuppressed persons who are infected with human immunodeficiency virus (HIV) and who have been previously infected with Mycobacterium tuberculosis. Increases in TB cases have occurred in areas which have reported large numbers of cases of the acquired immunodeficiency syndrome (AIDS), and a high proportion of these TB cases have been HIV seropositive. Therefore, increasing numbers of HIV-infected persons may be found in TB clinics and hospitals. HIV serologic surveys in TB clinics and hospitals providing clinical services to TB patients are needed to assess the local prevalence of HIV infection in TB patients and the consequent need for public health intervention to prevent further spread of HIV and TB infection. The Centers for Disease Control (CDC), in collaboration with State and local health departments, has initiated HIV surveillance of patients with confirmed and suspected TB in TB clinics and hospitals in the United States. Blinded (serologic test results not linked to identifiable persons) HIV seroprevalence surveys are conducted in sentinel TB clinics and hospitals that provide TB clinical services each year to obtain estimates of the level of HIV infection in TB patients and to follow trends in infection over time. Nonblinded (voluntary) surveys will also be conducted to evaluate behaviors that have placed TB patients at risk for or protected them against HIV infection. Data from these surveys will be used to target education and prevention and control programs for TB and HIV infection and to monitor changes in behavior in response to such programs.
McCray
E
E
Division of HIV/AIDS, Center for Infectious Disease, CDC, Atlanta, GA 30333.
Onorato
I M
IM
Miller
B I
BI
Dondero
T J
TJ
Bloch
A B
AB
D015492:AIDS Serodiagnosis / Q000379:methods; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D000328:Adult; D000554:Ambulatory Care Facilities; D006679:HIV Seropositivity / Q000453:epidemiology; D015528:HIV Seroprevalence; D006801:Humans; D008875:Middle Aged; D011159:Population Surveillance / Q000379:methods; D012307:Risk Factors; D012494:Sampling Studies; D014376:Tuberculosis / Q000150:complications / Q000276:immunology* / Q000517:prevention & control; D014481:United States / Q000453:epidemiology